445 related articles for article (PubMed ID: 32269380)
1. Modulation of regulatory T cell function and stability by co-inhibitory receptors.
Lucca LE; Dominguez-Villar M
Nat Rev Immunol; 2020 Nov; 20(11):680-693. PubMed ID: 32269380
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity.
Kumar P; Bhattacharya P; Prabhakar BS
J Autoimmun; 2018 Dec; 95():77-99. PubMed ID: 30174217
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
Ohue Y; Nishikawa H
Cancer Sci; 2019 Jul; 110(7):2080-2089. PubMed ID: 31102428
[TBL] [Abstract][Full Text] [Related]
4. Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis.
Kumar P; Saini S; Prabhakar BS
Semin Cancer Biol; 2020 Aug; 64():29-35. PubMed ID: 30716481
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory Receptors and Pathways of Lymphocytes: The Role of PD-1 in Treg Development and Their Involvement in Autoimmunity Onset and Cancer Progression.
Gianchecchi E; Fierabracci A
Front Immunol; 2018; 9():2374. PubMed ID: 30386337
[TBL] [Abstract][Full Text] [Related]
6. Expression of costimulatory and inhibitory receptors in FoxP3
Toker A; Ohashi PS
Adv Cancer Res; 2019; 144():193-261. PubMed ID: 31349899
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T cell metabolism at the intersection between autoimmune diseases and cancer.
Kurniawan H; Soriano-Baguet L; Brenner D
Eur J Immunol; 2020 Nov; 50(11):1626-1642. PubMed ID: 33067808
[TBL] [Abstract][Full Text] [Related]
8. Human FOXP3
Wing JB; Tanaka A; Sakaguchi S
Immunity; 2019 Feb; 50(2):302-316. PubMed ID: 30784578
[TBL] [Abstract][Full Text] [Related]
9. Treg-mediated acquired resistance to immune checkpoint inhibitors.
Saleh R; Elkord E
Cancer Lett; 2019 Aug; 457():168-179. PubMed ID: 31078738
[TBL] [Abstract][Full Text] [Related]
10. Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target.
Hashemi V; Maleki LA; Esmaily M; Masjedi A; Ghalamfarsa G; Namdar A; Yousefi M; Yousefi B; Jadidi-Niaragh F
Int Immunopharmacol; 2020 Jan; 78():106087. PubMed ID: 31841758
[TBL] [Abstract][Full Text] [Related]
11. One, No One, and One Hundred Thousand: T Regulatory Cells' Multiple Identities in Neuroimmunity.
Sambucci M; Gargano F; Guerrera G; Battistini L; Borsellino G
Front Immunol; 2019; 10():2947. PubMed ID: 31956323
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of human FoxP3
Attias M; Al-Aubodah T; Piccirillo CA
Clin Exp Immunol; 2019 Jul; 197(1):36-51. PubMed ID: 30864147
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Control of Treg Cell Stability, Plasticity, and Tissue-Specific Heterogeneity.
Shi H; Chi H
Front Immunol; 2019; 10():2716. PubMed ID: 31921097
[TBL] [Abstract][Full Text] [Related]
14. Targeting regulatory T cells in tumors.
Liu C; Workman CJ; Vignali DA
FEBS J; 2016 Jul; 283(14):2731-48. PubMed ID: 26787424
[TBL] [Abstract][Full Text] [Related]
15. Regulatory T-cell homeostasis: steady-state maintenance and modulation during inflammation.
Smigiel KS; Srivastava S; Stolley JM; Campbell DJ
Immunol Rev; 2014 May; 259(1):40-59. PubMed ID: 24712458
[TBL] [Abstract][Full Text] [Related]
16. Monitoring the frequency and function of regulatory T cells and summary of the approaches currently used to inhibit regulatory T cells in cancer patients.
Camisaschi C; Tazzari M; Rivoltini L; Castelli C
Methods Mol Biol; 2014; 1139():201-21. PubMed ID: 24619682
[TBL] [Abstract][Full Text] [Related]
17. In or out of control: Modulating regulatory T cell homeostasis and function with immune checkpoint pathways.
Abdeladhim M; Karnell JL; Rieder SA
Front Immunol; 2022; 13():1033705. PubMed ID: 36591244
[TBL] [Abstract][Full Text] [Related]
18. Targeting Treg cells in cancer immunotherapy.
Tanaka A; Sakaguchi S
Eur J Immunol; 2019 Aug; 49(8):1140-1146. PubMed ID: 31257581
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells: balancing protection versus pathology.
Rakebrandt N; Littringer K; Joller N
Swiss Med Wkly; 2016; 146():w14343. PubMed ID: 27497235
[TBL] [Abstract][Full Text] [Related]
20. The Janus face of CD4+CD25+ regulatory T cells in cancer and autoimmunity.
Danese S; Rutella S
Curr Med Chem; 2007; 14(6):649-66. PubMed ID: 17346153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
